ageless herbal products caucheteux approved quality  


   find us on Facebook

"We make living and aging a stunning experience…"

Click HERE to Shop in South Africa

For all official information and updates regarding COVID-19, visit the South African Department of Health's website at

Click HERE to Shop for the rest of the World

best quality anti-aging herbal products skin care body care hair care supplements capsules tablets

References used in Vitamin C information page

vitamin C ascorbic acid

  1. Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later? Cabanillas F. P R Health Sci J. 2010 Sep;29(3):215-7.
  2. Catalytic therapy of cancer by ascorbic acid involves redox cycling of exogenous/endogenous copper ions and generation of reactive oxygen species. Hadi SM, Ullah MF, Shamim U, Bhatt SH, Azmi AS. Chemotherapy. 2010;56(4):280-4
  3. Cellular pathways for transport and efflux of ascorbate and dehydroascorbate. Corti A, Casini AF, Pompella A. Arch Biochem Biophys. 2010 Aug 15;500(2):107-15.
  4. Vitamin C in complementary oncology--update 2009. Gröber U. Med Monatsschr Pharm. 2009 Jul;32(7):263-7.
  5. Regular Consumption of Concord Grape Juice Benefits Human Immunity. Rowe CA, Nantz MP, Nieves C, West RL, Percival SS. J Med Food. 2010 Dec 7.
  6. Organic foods contain higher levels of certain nutrients, lower levels of pesticides, and may provide health benefits for the consumer. Crinnion WJ. Altern Med Rev. 2010 Apr;15(1):4-12.
  7. Vitamin C and the role of citrus juices as functional food. Martí N, Mena P, Cánovas JA, Micol V, Saura D. Nat Prod Commun. 2009 May;4(5):677-700.
  8. Vitamin C treatment reduces elevated C-reactive protein. Block G, Jensen CD, Dalvi TB, Norkus EP, Hudes M, Crawford PB, Holland N, Fung EB, Schumacher L, Harmatz P. Free Radic Biol Med. 2009 Jan 1;46(1):70-7.
  9. Ehlers-Danlos Syndrome, Classic Type. Wenstrup R, De Paepe A. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. 1993-.2007 May 29 [updated 2010 May 11].
  10. Nutrition and bone health. Roles of vitamin C and vitamin B as regulators of bone mass and quality. Saito M. Clin Calcium. 2009 Aug;19(8):1192-9.
  11. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Harrison FE, May JM. Free Radic Biol Med. 2009 Mar 15;46(6):719-30.
  12. Inflammation in the vascular bed: importance of vitamin C. Aguirre R, May JM. Pharmacol Ther. 2008 Jul;119(1):96-103.
  13. Vitamin C. Valdés F. Actas Dermosifiliogr. 2006 Nov;97(9):557-68.
  14. Biological role of vitamin C in keratinocytes. Catani MV, Savini I, Rossi A, Melino G, Avigliano L. Nutr Rev. 2005 Mar;63(3):81-90.
  15. New developments and novel therapeutic perspectives for vitamin C. Li Y, Schellhorn HE. J Nutr. 2007 Oct;137(10):2171-84.
  16. Vitamins C and E: missing links in preventing preterm premature rupture of membranes? Woods JR Jr, Plessinger MA, Miller RK. Am J Obstet Gynecol. 2001 Jul;185(1):5-10.
  17. The modern approach to wound treatment. Komarcevic A. Med Pregl. 2000 Jul-Aug;53(7-8):363-8.
  18. Cellular functions of ascorbic acid. Padh H. Biochem Cell Biol. 1990 Oct;68(10):1166-73.
  19. Human vitamin C requirements. Gerster H. Z Ernahrungswiss. 1987 Jun;26(2):125-37.
  20. Vitamin C and human wound healing. Ringsdorf WM Jr, Cheraskin E. Oral Surg Oral Med Oral Pathol. 1982 Mar;53(3):231-6.
  21. Ascorbic acid and cancer: a Cameron E, Pauling L, Leibovitz B. Cancer Res. 1979 Mar;39(3):663-81.
  22. Ascorbic acid for the healing of skin wounds in rats. Lima CC, Pereira AP, Silva JR, Oliveira LS, Resck MC, Grechi CO, Bernardes MT, Olímpio FM, Santos AM, Incerpi EK, Garcia JA. Braz J Biol. 2009 Nov;69(4):1195-201.
  23. Anti-angiogenic effect of high doses of ascorbic acid. Mikirova NA, Ichim TE, Riordan NH. J Transl Med. 2008 Sep 12;6:50.
  24. Anti-aging research using SMP30/GNL knockout mice. Ishigami A. Yakugaku Zasshi. 2010 Jan;130(1):25-8.
  25. Multivitamin use and telomere length in women. Xu Q, Parks CG, DeRoo LA, Cawthon RM, Sandler DP, Chen H. Am J Clin Nutr. 2009 Jun;89(6):1857-63.
  26. High vitamin C intake is associated with lower 4-year bone loss in elderly men. Sahni S, Hannan MT, Gagnon D, Blumberg J, Cupples LA, Kiel DP, Tucker KL. J Nutr. 2008 Oct;138(10):1931-8.
  27. Dietary nutrient intakes and skin-aging appearance among middle-aged American women. Cosgrove MC, Franco OH, Granger SP, Murray PG, Mayes AE. Am J Clin Nutr. 2007 Oct;86(4):1225-31. Erratum in: Am J Clin Nutr. 2008 Aug;88(2):480.
  28. Antioxidant nutrient intake and the long-term incidence of age-related cataract: the Blue Mountains Eye Study. Tan AG, Mitchell P, Flood VM, Burlutsky G, Rochtchina E, Cumming RG, Wang JJ. Am J Clin Nutr. 2008 Jun;87(6):1899-905.
  29. Blood levels of vitamin C, carotenoids and retinol are inversely associated with cataract in a North Indian population. Dherani M, Murthy GV, Gupta SK, Young IS, Maraini G, Camparini M, Price GM, John N, Chakravarthy U, Fletcher AE. Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3328-35.
  30. Vitamins E and C are safe across a broad range of intakes. Hathcock JN, Azzi A, Blumberg J, Bray T, Dickinson A, Frei B, Jialal I, Johnston CS, Kelly FJ, Kraemer K, Packer L, Parthasarathy S, Sies H, Traber MG. Am J Clin Nutr. 2005 Apr;81(4):736-45.
  31. Vitamin C in human health and disease is still a mystery? Naidu KA. Nutr J. 2003 Aug 21;2:7.
  32. Aspects of free radical reactions in biological systems: aging. Leibovitz BE, Siegel BV. J Gerontol. 1980 Jan;35(1):45-56.
  33. Vitamin C restores healthy aging in a mouse model for Werner syndrome. Massip L, Garand C, Paquet ER, Cogger VC, O'Reilly JN, Tworek L, Hatherell A, Taylor CG, Thorin E, Zahradka P, Le Couteur DG, Lebel M. FASEB J. 2010 Jan;24(1):158-72.
  34. Mercury elimination with oral DMPS, DMSA, vitamin C, and glutathione: an observational clinical Muran PJ. Altern Ther Health Med. 2006 May-Jun;12(3):70-5.
  35. Effects of vitamin C on A549 cell proliferation, apoptosis and expressions of Caspase, Survivin. Zhai P, Zeng J, Tan N, Wang J, Huang L, She W. Zhongguo Fei Ai Za Zhi. 2010 Feb;13(2):89-93.
  36. Anesthetic experience of methemoglobinemia detected during general anesthesia for gastrectomy of advanced gastric cancer. Cho SS, Park YD, Noh JH, Kang KO, Jun HJ, Yoon JS. Korean J Anesthesiol. 2010 Nov;59(5):340-3.
  37. Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase. Fong JE, Le Nihouannen D, Komarova SV. J Biol Chem. 2010 Oct 8;285(41):31427-34.
  38. Micronutrient synergy--a new tool in effective control of metastasis and other key mechanisms of cancer. Niedzwiecki A, Roomi MW, Kalinovsky T, Rath M. Cancer Metastasis Rev. 2010 Sep;29(3):529-42.
  39. Anticancer vitamins du Jour--The ABCED's so far. Byers T. Am J Epidemiol. 2010 Jul 1;172(1):1-3
  40. Synergistic effects of tea polyphenols and ascorbic acid on human lung adenocarcinoma SPC-A-1 cells. Li W, Wu JX, Tu YY. J Zhejiang Univ Sci B. 2010 Jun;11(6):458-64.

References used in above references

  1. Jaffé ER. Methaemoglobinaemia. Clin Haematol. 1981;10:99–122.
  2. Curry S. Methemoglobinemia. Ann Emerg Med. 1982;11:214–221.
  3. Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med. 1999;34:646–656.
  4. Mayo W, Leighton K, Robertson B, Ruedy J. Intraoperative cyanosis: a case of dapsone-induced methaemoglobinaemia. Can J Anaesth. 1987;34:79–82.
  5. Talarico JF, Metro DG. Presentation of dapsone-induced methemoglobinemia in a patient status post small bowel transplant. J Clin Anesth. 2005;17:568–570.
  6. Yang JJ, Lin N, Lv R, Sun J, Zhao F, Zhang J, et al. Methemoglobinemia misdiagnosed as ruptured ectopic pregnancy. Acta Anaesthesiol Scand. 2005;49:586–588.
  7. Haymond S, Cariappa R, Eby CS, Scott MG. Laboratory assessment of oxygenation in methemoglobinemia. Clin Chem. 2005;51:434–444.
  8. Baraka AS, Ayoub CM, Kaddoum RN, Maalouli JM, Chehab IR, Hadi UM. Severe oxyhemoglobin desaturation during induction of anesthesia in a patient with congenital methemoglobinemia. Anesthesiology. 2001;95:1296–1297.
  9. Khan NA, Kruse JA. Methemoglobinemia induced by topical anesthesia: a case report and Am J Med Sci. 1999;318:415–418.
  10. Harvey JW, Keitt AS. Studies of the efficacy and potential hazards of methylene blue therapy in aniline-induced methaemoglobinaemia. Br J Haematol. 1983;54:29–41.
  11. Morgan G, Ward R, Barton M. The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. Clinical Oncology. 2004;16(8):549–560. doi: 10.1016/j.clon.2004.06.007.
  12. Aldercreutz H. Western diet and Western disease: some hormonal and biochemical mechanisms and associations. Scandinavian Journal of Clinical and Laboratory Investigation Supplementation. 1990;201:3–23. doi: 10.3109/00365519009085798.
  13. Miller AB. Diet and Cancer: A Acta Oncológica. 1990;29(1):87–95. doi: 10.3109/02841869009089996.
  14. Rath M, Pauling L. Plasmin-induced proteolysis and the role of apoprotein(a), lysine and synthetic analogs. Orthomolecular Medicine. 1992;7:17–23.
  15. Almholt K, Lundt LR, Rygaard J, Nielsen BS, Danø K, Rømer J, Johnsen M. Reduced metastasis of transgenic mammary cancer in urokinse-deficient mice. International Journal of Cancer. 2005;113(4):525–532. doi: 10.1002/ijc.20631.
  16. Stetler-Stevenson WG. The role of matrix metalloproteinases in tumor invasion, metastasis and angiogenesis. Surgical Oncology Clinics of North America. 2001;10:383–392.
  17. Duffy MJ. The role of proteolytic enzymes in cancer invasion and metastasis. Clinical & Experimental Metastasis. 1992;10:145–155. doi: 10.1007/BF00132746.
  18. Chambers AF, Matrisian LM. Changing views on the role of matrix metalloprotenases in metastasis. Journal of the National Cancer Institute. 1997;89(17):1260–1270. doi: 10.1093/jnci/89.17.1260.
  19. Kleiner DL, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemotherapy and Pharmacology. 1999;43(suppl):42s–51s. doi: 10.1007/s002800051097.
  20. Liotta LA, Tryggvason K, Garbisa A, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980;284:67–68. doi: 10.1038/284067a0.
  21. Stetler-Stevenson WG, Hewitt R, Corcoran M. Matrix metalloproteinases and tumor invasion from correlation and causality to the clinic. Seminars in Cancer Biology. 1996;7:147–154. doi: 10.1006/scbi.1996.0020.
  22. Ivanov V, Ivanova S, Roomi MW, Kalinovsky T, Niedzwiecki A, Rath M. Naturally-produced extracellular matrix inhibits growth rate and invasiveness of human osteosarcoma cancer cells. Medical Oncology. 2007;24(2):209–217. doi: 10.1007/BF02698042.
  23. Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. Inhibition of pulmonary metastasis of melanoma B16FO cells in C57BL/6 mice by a nutrient mixture consisting of ascorbic acid, lysine, proline, arginine, and green tea extract. Experimental Lung Research. 2006;32(10):517–530. doi: 10.1080/01902140601098552.
  24. Roomi MW, Roomi N, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. Inhibitory effect of a mixture containing ascorbic acid, lysine, proline, and green tea extract on critical parameters in angiogenesis. Oncology Reports. 2005;14(4):807–815.
  25. Sun Z, Chen YH, Wang P, Zhang J, Gurewich V, Zhang P, Liu JN. The blockage of high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation. Biochem Biophys Acta. 2002;1596:182–192.
  26. Kemberling JK, Hampton JA, Keck RW, Gomez MA, Selman SH. Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate. Journal d’Urologie. 2003;170(3):773–776.
  27. Sato D, Matsushima M. Preventive effects of urinary bladder tumors induced by N- butyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves. International Journal of Urology. 2003;10(3):160–166. doi: 10.1046/j.1442-2042.2003.00587.x.
  28. Valcic S, Timmermann BN, Alberts DS, Wachter GA, Krutzsch M, Wymer J, Guillen JM. Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anti-Cancer Drugs. 1996;7:461–468. doi: 10.1097/00001813-199606000-00011.
  29. Mukhtar H, Ahmed N. Tea polyphenols: Prevention of cancer and optimizing health. The American Journal of Clinical Nutrition. 2000;71:1698s–1702s.
  30. Yang GY, Liao J, Kim K, Yurtow EJ, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis. 1998;19:611–616. doi: 10.1093/carcin/19.4.611.
  31. Taniguchi S, Fujiki H, Kobayashi H, Go H, Miyado K, Sadano H, Shimikawa R. Effect of (-) epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Letters. 1992;65:51–54. doi: 10.1016/0304-3835(92)90212-E.
  32. Hara Y. Green tea: Health Benefits and Applications. New York: Marcel Dekker; 2001.
  33. Kawakami S, Kageyama Y, Fujii Y, Kihara K, Oshima H. Inhibitory effects of N- acetyl cysteine on invasion and MMP 9 production of T24 human bladder cancer cells. Anticancer Research. 2001;21:213–219.
  34. Morini M, Cai T, Aluigi MG, Noonan DM, Masiello L, Floro S, D’Agostinin F, Albini A, Fassima G. The role of the thiol N-acetyl cysteine in the prevention of tumor invasion and angiogenesis. The International Journal of Biological Markers. 1999;14:268–271.
  35. Yoon SO, Kim MM, Chung AS. Inhibitory effects of selenite on invasion of HT 1080 tumor cells. The Journal of Biological Chemistry. 2001;276:20085–20092. doi: 10.1074/jbc.M101143200.
  36. 27. Maramag C, Menon M, Balaji KC, Reddy PG, Laxmanan S. Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability and DNA synthesis. The Prostate. 1997;32:188–195. doi: 10.1002/(SICI)1097-0045(19970801)32:3<188::AID-PROS5>3.0.CO;2-H.
  37. Koh WS, Lee SJ, Lee H, Park C, Park MH, Kim WS, Yoon SS, Park K, Hong SI, Chung MH, Park CH. Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines. Anticancer Research. 1998;8:2487–2493.
  38. Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E, Levine M. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. PNAS. 2005;102(38):13604–13609. doi: 10.1073/pnas.0506390102.
  39. Nunez C, Ortiz de Apodaca Y, Ruiz A. Ascorbic acid in the plasma and blood cells of women with breast cancer. The effect of consumption of food with an elevated content of this vitamin. Nutrición Hospitalaria. 1995;10:68–372.
  40. Kurbacher CM, Wagner U, Kolster B, Andreotti PE, Krebs D, Bruckner HW. Ascorbic acid (vitamin C) improves the antineoplastic activity doxorubicin, cisplatin and paclitaxel in human breast carcinoma cells in vitro. Cancer Letters. 1996;103(2):183–189. doi: 10.1016/0304-3835(96)04212-7.
  41. Cooke JP, Dzau VJ. Nitric oxide synthase: Role in the genesis of vascular disease. Annual Review of Medicine. 1997;48:489–509. doi: 10.1146/
  42. Kale A, Gawande S, Kotwal S, Netke S, Roomi MW, Ivanov V, Niedzwiecki A, Rath M. A combination of green tea extract, specific nutrient mixture and quercetin: An effective intervention treatment for the regression of N-methyl-N-nitrosourea (MNU)-induced mammary tumors in Wistar rats. Onc Letters. 2010;1:313–317.
  43. Roomi MW, Roomi NW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. Modulation of N-methyl-N-nitrosourea induced mammry tumors in Sprague–Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Research. 2005;7:R291–R295. doi: 10.1186/bcr989.
  44. Roomi MW, Roomi NW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. Inhibition of pulmonary metastasis of melanoma B16FO cells in C57BL/6 mice by a nutrient mixture consisting of ascorbic acid, lysine, proline, arginine, and green tea extract. Experimental Lung Research. 2006;32:517–530. doi: 10.1080/01902140601098552.
  45. Roomi MW, Kalinovsky T, Roomi NW, Monterrey J, Rath M, Niedzwiecki A. A nutrient mixture suppresses hepatic metastasis in athymic nude mice injected with murine B16FO melanoma cells. Biofactors. 2009;33:181–189. doi: 10.1002/biof.5520330304.
  46. Roomi MW, Kalinovsky T, Roomi NW, Monterrey J, Rath M, Niedzwiecki A. Suppression of growth and hepatic metastasis of murine B16FO melanoma cells by a novel nutrient mixture. Oncology Report. 2008;20:809–817.
  47. Roomi, M. W., Roomi, N. W., Rath, M., Niedzwiecki, A. (2009). Downregulation of urokinase plasminogen activiator (u-PA), matrix metalloproteinases (MMPs) and upregulation of their inhibitors (TIMPs) by a novel nutrient mixture in human prostate cancer cell lines PC-3 and Du-145. Proceedings of the 100thAnnual Meeting of the AACR 2009, abstract 2217, p. 270.
  48. Roomi MW, Kalinovsky T, Niedzwiecki A, Rath M. Pleiotropic effects of a micronutrient mixture on critical parameters of bladder cancer. In: Nilsson WE, editor. Bladder cancer etymology, diagnosis and treatments. New York: Nova Science Publishers Inc; 2009.
  49. Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. In vitro anticarcinogenic effect of a nutrient mixture on human rhabdomyosarcoma cells. Gene Therapy and Molecular Biology. 2007;11:133–142.
  50. Harakeh S, Diab-Assaf M, Niedzwiecki A, Khalife JC, Abu-El-Ardat K, Rath M. Apoptosis induction by Epican Forte in HTLV-1 positive and negative malignant T-cells. Leukemia Research. 2006;30(7):869–881. doi: 10.1016/j.leukres.2005.11.027.
  51. Ivanov V, Cha J, Ivanova S, Kalinovsky T, Roomi MW, Rath M, Niedzwiecki A. Essential nutrients suppress inflammation by modulating key inflammatory gene expression. International Journal of Molecular Medicine. 2008;22(6):731–742.
  52. Roomi MW, Ivanov V, Netke SP, Niedzwiecki A, Rath M. Serum markers of the liver, heart, and kidney and lipid profile and histopathology in ODS rats treated with nutrient synergy. Journal of the American College of Nutrition. 2003;22:477.
  53. Coleman, R. E. (2006) Clin. Cancer Res. 12, 6243S–6249S
  54. Kim,C. J., Bland,K. I., and Yeatman,T. J. (2004)The Breast Comprehensive Management of Benign and Malignant Disorders, W. B. Saunders, Philadelphia, PA
  55. Hattner, R., Epker, B. N., and Frost, H. M. (1965) Nature 206, 489–490
  56. Stenbeck, G. (2002) Semin. Cell Dev. Biol. 13, 285–292
  57. Deng, Z. L., Sharff, K. A., Tang, N., Song,W. X., Luo, J., Luo, X., Chen, J., Bennett, E., Reid, R., Manning, D., Xue, A., Montag, A. G., Luu, H. H., Haydon, R. C., and He, T. C. (2008) Front. Biosci. 13, 2001–2021
  58. Engin, F., Yao, Z., Yang, T., Zhou, G., Bertin, T., Jiang, M. M., Chen, Y., Wang, L., Zheng, H., Sutton, R. E., Boyce, B. F., and Lee, B. (2008) Nat. Med. 14, 299–305
  59. Hilton,M. J., Tu, X.,Wu, X., Bai, S., Zhao, H., Kobayashi, T., Kronenberg, H. M., Teitelbaum, S. L., Ross, F. P., Kopan, R., and Long, F. (2008) Nat. Med. 14, 306–314
  60. Mendoza, M., and Khanna, C. (2009) Int. J. Biochem. Cell Biol. 41, 1452–1462
  61. Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., Zhu, Z., Hicklin, D., Wu, Y., Port, J. L., Altorki, N., Port, E. R., Ruggero, D., Shmelkov, S. V., Jensen, K. K., Rafii, S., and Lyden, D. (2005) Nature 438, 820–827
  62. Kaplan, R. N., Psaila, B., and Lyden, D. (2006) Cancer Metastasis Rev. 25, 521–529
  63. Wang, J., Loberg, R., and Taichman, R. S. (2006) Cancer Metastasis Rev. 25, 573–587
  64. Neiva, K., Sun, Y. X., and Taichman, R. S. (2005) Braz. J.Med. Biol. Res. 38, 1449–1454
  65. Calvi, L. M., Adams, G. B., Weibrecht, K. W., Weber, J. M., Olson, D. P., Knight, M. C., Martin, R. P., Schipani, E., Divieti, P., Bringhurst, F. R., Milner, L. A., Kronenberg, H. M., and Scadden, D. T. (2003) Nature 425, 841–846
  66. Shiozawa, Y., Havens, A. M., Pienta, K. J., and Taichman, R. S. (2008) Leukemia 22, 941–950
  67. Mercer, R. R.,Miyasaka,C., andMastro,A.M. (2004)Clin. Exp.Metastasis 21, 427–435
  68. Fromigue´,O., Kheddoumi,N., Lomri, A.,Marie, P. J., and Body, J. J. (2001) J. Bone Miner. Res. 16, 1600–1610
  69. Phadke, P. A., Mercer, R. R., Harms, J. F., Jia, Y., Frost, A. R., Jewell, J. L., Bussard, K. M., Nelson, S., Moore, C., Kappes, J. C., Gay, C. V., Mastro, A. M., andWelch, D. R. (2006) Clin. Cancer Res. 12, 1431–1440
  70. Bu, G., Lu, W., Liu, C. C., Selander, K., Yoneda, T., Hall, C., Keller, E. T., and Li, Y. (2008) Int. J. Cancer 123, 1034–1042
  71. Lau, Y. S., Danks, L., Sun, S. G., Fox, S., Sabokbar, A., Harris, A., and Athanasou, N. A. (2007) Breast Cancer Res. Treat. 105, 7–16
  72. Chen, H. L., Demiralp, B., Schneider, A., Koh, A. J., Silve, C.,Wang, C. Y., and McCauley, L. K. (2002) J. Biol. Chem. 277, 19374–19381
  73. Dougall, W. C., and Chaisson, M. (2006) Cancer Metastasis Rev. 25, 541–549
  74. Thomas, R. J.,Guise, T. A., Yin, J. J., Elliott, J.,Horwood,N. J.,Martin, T. J., and Gillespie, M. T. (1999) Endocrinology 140, 4451–4458
  75. Zhu, J., Jia, X., Xiao,G., Kang, Y., Partridge,N. C., andQin, L. (2007) J. Biol. Chem. 282, 26656–26664
  76. Stewart, A. F., Vignery, A., Silverglate, A., Ravin, N. D., LiVolsi, V., Broadus, A. E., and Baron, R. (1982) J. Clin. Endocrinol. Metab. 55, 219–227
  77. Taube,T., Elomaa, I., Blomqvist,C., Beneton,M.N., andKanis, J.A. (1994) Bone 15, 161–166
  78. Guo, Y., Tiedemann, K., Khalil, J. A., Russo, C., Siegel, P. M., and Komarova, S. V. (2008) Bone 43, 386–393
  79. Tiedemann, K., Hussein, O., Sadvakassova, G., Guo, Y., Siegel, P. M., and Komarova, S. V. (2009) J. Biol. Chem. 284, 33662–33670
  80. Guise, T. A., and Mundy, G. R. (1998) Endocr. Rev. 19, 18–54
  81. Chirgwin, J.M., andGuise, T.A. (2000) Crit. Rev. Eukaryot.Gene Expr. 10, 159–178
  82. Guise, T. A., and Chirgwin, J. M. (2003) Clin. Orthop. Relat. Res. 415, S32–S38
  83. Varnum-Finney, B., Purton, L. E., Yu,M., Brashem-Stein, C., Flowers, D., Staats, S.,Moore, K. A., Le Roux, I.,Mann, R., Gray, G., Artavanis-Tsakonas, S., and Bernstein, I. D. (1998) Blood 91, 4084–4091
  84. Engin, F., Bertin, T., Ma, O., Jiang, M. M., Wang, L., Sutton, R. E., Donehower, L. A., and Lee, B. (2009) Hum. Mol. Genet. 18, 1464–1470
  85. Shih, IeM., andWang, T. L. (2007) Cancer Res. 67, 1879–1882
  86. Armstrong, S., Pereverzev,A.,Dixon, S. J., and Sims, S.M. (2009) J.Cell Sci. 122, 136–144
  87. Komarova, S. V., Pereverzev, A., Shum, J.W., Sims, S.M., and Dixon, S. J. (2005) Proc. Natl. Acad. Sci. U.S.A. 102, 2643–2648
  88. Komarova, S. V., Pilkington,M. F.,Weidema, A. F., Dixon, S. J., and Sims, S. M. (2003) J. Biol. Chem. 278, 8286–8293
  89. Canalis, E. (2008) Sci. Signal. 1, pe17
  90. Taichman, R. S., and Emerson, S. G. (1998) Stem Cells 16, 7–15
  91. Zhang, J., Niu, C., Ye, L., Huang, H., He, X., Tong,W. G., Ross, J., Haug, J., Johnson, T., Feng, J. Q., Harris, S.,Wiedemann, L.M.,Mishina, Y., and Li, L. (2003) Nature 425, 836–841
  92. Gori, F., Hofbauer, L. C., Dunstan, C. R., Spelsberg, T. C., Khosla, S., and Riggs, B. L. (2000) Endocrinology 141, 4768–4776
  93. Thomas, G. P., Baker, S. U., Eisman, J. A., and Gardiner, E. M. (2001) J. Endocrinol. 170, 451–460
  94. Baldock, P. A., Thomas, G. P., Hodge, J. M., Baker, S. U., Dressel, U., O’Loughlin, P. D., Nicholson, G. C., Briffa, K. H., Eisman, J. A., and Gardiner, E. M. (2006) J. Bone Miner. Res. 21, 1618–1626
  95. Holmen, S. L., Zylstra, C. R., Mukherjee, A., Sigler, R. E., Faugere, M. C., Bouxsein,M. L.,Deng, L.,Clemens,T. L., andWilliams, B.O. (2005) J. Biol. Chem. 280, 21162–21168
  96. Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M. S., Dwyer, D., Korb, A., Smolen, J., Hoffmann, M., Scheinecker, C., van der Heide, D., Landewe, R., Lacey, D., Richards,W. G., and Schett, G. (2007) Nat. Med. 13, 156–163
  97. Qiang, Y. W., Chen, Y., Stephens, O., Brown, N., Chen, B., Epstein, J., Barlogie, B., and Shaughnessy, J. D., Jr. (2008) Blood 112, 196–207
  98. Siegel, P. M., and Massague´, J. (2003) Nat. Rev. Cancer 3, 807–821
  99. Yin, J. J., Selander, K.,Chirgwin, J.M.,Dallas,M.,Grubbs, B.G.,Wieser, R., Massague´, J., Mundy, G. R., and Guise, T. A. (1999) J. Clin. Invest. 103, 197–206
  100. Kang, Y., He, W., Tulley, S., Gupta, G. P., Serganova, I., Chen, C. R., Manova-Todorova, K., Blasberg, R.,Gerald,W. L., andMassague´, J. (2005) Proc. Natl. Acad. Sci. U.S.A. 102, 13909–13914
  101. Deckers, M., van Dinther, M., Buijs, J., Que, I., Lo¨wik, C., van der Pluijm, G., and ten Dijke, P. (2006) Cancer Res. 66, 2202–2209
  102. Yamada, T., Yamazaki, H., Yamane, T., Yoshino, M., Okuyama, H., Tsuneto, M., Kurino, T., Hayashi, S., and Sakano, S. (2003) Blood 101, 2227–2234
  103. Bai, S., Kopan, R., Zou,W., Hilton, M. J., Ong, C. T., Long, F., Ross, F. P., and Teitelbaum, S. L. (2008) J. Biol. Chem. 283, 6509–6518
  104. Kollet, O., Dar, A., Shivtiel, S., Kalinkovich, A., Lapid, K., Sztainberg, Y., Tesio,M., Samstein, R.M., Goichberg, P., Spiegel, A., Elson, A., and Lapidot, T. (2006) Nat. Med. 12, 657–664
  105. Ziegler RG, Byers T. Re: Health claims about vitamin C and cancer. J Natl Cancer Inst. 1994;86(11):871–872.
Ageless herbal product range

Our Ageless herbal product range

Skin care

  • Healing cream
    • To assist in wound healing while soothing skin complaints – such as eczema and psoriasis, acne and piles and moisturizing and protecting the skin. This product has shown its effectiveness over a wide range of problems and judging from sales over more than a decade – it is the trusted healing cream to help with all mishaps, allergic reactions, irritated, burning, itchy and uncomfortable skin conditions.
  • Face wash
    • This face wash will properly clean your face and remove all impurities and environmental pollutants, without drying the skin. It contains eight herbal extracts to help promote a clear, vital and healthy complexion and a younger looking skin.
  • Moisturizing day cream
    • This day cream is formulated to help fight the signs of aging on various fronts. It helps to reduce free radical damage which, if left unchecked, leads to premature aging. The herbal extracts help to promote cell rejuvenation and regeneration and provide moisture and hydration to the skin.
  • Nourishing night cream
    • This nourishing night cream penetrates the skin extremely well and does not make the skin feel oily. It contains a host of herbal extracts to help in the fight against premature aging and has added vitamin E as well. Apart from the moisturizing effect and the anti-aging properties it also softens and smoothes the skin.
  • Eye gel
    • An effective refreshing eye gel to help reduce puffiness and dark rings around the eyes, while fighting wrinkles and lines. This is a very clever combination of herbal extracts and the base formula has its roots in a clinically proven formula.
  • Mud face mask
    • With this skin treatment product we combined a special selection of herbs in a base of thermal mud with oligoelements. This recommended weekly treatment will boost circulation to the skin, help to fight wrinkles and lines, improve firmness while at the same time improving suppleness and elasticity of the skin.


Hair care

  • Shampoo with rosemary extract + 7 other herbals
    • Our shampoo is in a class of its own – and granted – it is far more expensive than cheap supermarket shampoos, but no other shampoo has the active ingredients we have in our shampoo. The rosemary will boost the health of the hair and scalp, while the other seven herbal extracts will help strengthen the hair and make it shine, increase the volume and make it manageable.
  • Rosemary hair treatment conditioner
    • We have found that this hair conditioner should really be used as a conditioning treatment. This then removes the need to condition the hair every time you wash – and can be used once a month. It is a superb hair tonic and helps in the control of sebum secretion of the scalp. Although not formulated for dandruff – the ingredients will assist with this as well, while supporting the health of the scalp.


Specialized herbal gels and lotions

  • Hand and body lotion
    • When formulating this hand and body lotion we created a rich nourishing, protecting and reviving lotion, which will not leave the skin oily or tacky, but will create a well moisturized, hydrated and supple skin. After applying this lotion it will quickly be absorbed by the skin, leaving it silky soft, smooth and well moisturized.
  • Stretch mark gel
    • Although nothing can remove already formed stretch marks (only surgery can do that) – thousands of satisfied clients confirm that this gel improves the appearance of old stretch marks. The gel will help in PREVENTING stretch marks (a 92% success rate) and is used with great success by expectant mothers and body builders who may form marks when bulking-up. The formula of this gel is based on clinical studies done in France, to which we added other herbal extracts.


Herbal supplements


Other products

  • Jojoba oil
    • This liquid golden ester not only moisturizes and penetrates the skin but also helps to fight wrinkles and lines while promoting a clear and unblemished skin. Jojoba does not clog the pores but helps to restore skin elasticity and smoothness. It will leave the skin supple and velvety soft without any oiliness and can be used neat on the skin.
  • Almond oil
    • This light and deeply moisturizing oil has a softening effect on the skin and can be used on the face and body. Almond oil has excellent emollient properties and helps to balance water and moisture loss in the skin. It can be used neat on the skin and also makes an excellent massage base.
pci dss compliant
website and shopping security
sallamander concepts
Ageless essential oils
Agelesshealth South African herbal and essential oils products


Information contained on this website is for general information purposes only
and must not be used to treat or diagnose medical conditions.

All health problems must be referred to a health care professional.

Statements made regarding the products, ingredients and general information
have not been evaluated by the FDA or SAHPRA and should not be seen as health claims.

All ingredients used in our products are safe and are not banned, controlled or restricted.

All products are manufactured in licensed laboratories following strict GMP and ISO standards.

Our site was last updated on 25 Oct 2023

© Sallamander Manufacturing CC 2006 - 2023